The South America biomedical sensors market size was valued at USD 0.54 billion in 2025 and is estimated to expand from USD 0.61 billion in 2026 to reach USD 1.09 billion by 2031, at a CAGR of 12.31% during the forecast period (2026-2031). This report is segmented by Connectivity Type (Wired, and Wireless), Sensor Type (Temperature, Pressure, Image Sensors, and More), End-User Industry (Pharmaceutical, Healthcare, Research Institutions, and More), Application (Diagnostics, Monitoring, Therapeutics, Imaging, Research and Development, and More), and Geography. The Market Forecasts are Provided in Terms of Value (USD).
Other drivers and restraints analyzed in the detailed report include:
Wireless sensors are expected to expand at a 12.71% CAGR through 2031. Their use is increasing in step-down units, outpatient pathways, remote monitoring, and home discharge programs. Wired and wireless systems often complement each other rather than replace one another. Philips showcased its PM 6000 patient monitoring platform, featuring the Patient Information Center iX software, in Brazil in May 2026. The platform illustrates how continuous monitoring in critical care can sit alongside wireless data access and early-warning tools for wider hospital use.
Temperature sensors held 31.18% of the South America biomedical sensors market share in 2025. Their broad use covers patient monitoring, pharmaceutical cold-chain management, research laboratories, neonatal care, and critical care. Temperature is a basic clinical measurement that is in high demand across many settings. Pressure, image, inertial, motion, and electrocardiogram sensors serve more specialized needs in diagnostics, cardiovascular care, and imaging-guided procedures. Together, these categories make the South America biomedical sensors industry relevant to both general monitoring and targeted clinical applications.
Biochemical sensors are projected to expand at a 13.89% CAGR through 2031. Demand is linked to diabetes management and wider use of continuous glucose monitoring. Adult diabetes prevalence in the Americas was 13.1% in the 2025 PAHO data. Abbott received FDA authorization for Libre Duo 10 Day in August 2026, a dual glucose-ketone sensor designed to monitor both analytes. FAPESP also supported a 2025 project for a dual-impedimetric platform that monitors glucose and C-peptide using nanocomposite electrodes.
South America Biomedical Sensors Market Trends and Insights
Rising Chronic Disease Burden and Demand for Continuous Monitoring
Chronic disease is creating a durable need for monitoring across South American care systems. Noncommunicable disease deaths in the Americas reached 6 million in 2021, up 43% from 2000. Cardiovascular disease caused 2.16 million of those deaths, while diabetes caused more than 420,000 deaths, and chronic respiratory conditions caused more than 416,000 deaths. More than 43 million people aged over 30 lacked the care they needed, which increases the importance of monitoring beyond specialist facilities. A 2026 study placed the annual cost of atherosclerotic cardiovascular disease in Brazil at BRL 10 billion (USD 1.8 billion). Brazil also announced BRL 2.4 billion (USD 480 million) in SUS equipment procurement in August 2025, with preferential pricing for domestic manufacturers.Expansion of Home-Based Care and Remote Patient Monitoring
Home-based care has become an established part of healthcare delivery in the region. The South America remote patient monitoring systems category is expected to increase from USD 254.13 million in 2025 to USD 576 million by 2030, at a 17.78% CAGR. This shift extends the use of sensors into homes, community settings, and post-discharge programs. It also makes accuracy, calibration, and dependable connectivity important because home-use devices must still support clinical decisions. The resulting demand does not favor low-cost devices alone, since providers need evidence that a sensor performs reliably outside a hospital. The South America biomedical sensors market can benefit when suppliers combine validated hardware with services that support remote clinical workflows.Data Security and Patient Privacy Vulnerabilities
Connected sensors increase the volume of patient information moving across digital systems. A 2025 study of Brazil’s DATASUS platform identified a risk that authorized users could infer sensitive attributes by combining demographic and procedural data. That concern is relevant because sensor-enabled systems increasingly feed information into national and hospital data environments. Brazil’s Decree No. 12.560 of July 2025 revised governance for the National Health Data Network and required data sovereignty, confidentiality, and auditability. Compliance work can delay procurement when healthcare providers need assurance that a vendor’s practices meet LGPD obligations. This can create a higher barrier to entry for smaller connected-device suppliers in the South America biomedical sensors market.Other drivers and restraints analyzed in the detailed report include:
- Integration of Biomedical Sensors With IoT and Wireless Medical Devices
- Growth of Point-of-Care Diagnostics and Decentralized Testing
- Stringent Regulatory Procedures and Long Product-Development Cycles
Segment Analysis
Wired sensors held 53.72% of the South America biomedical sensors market share in 2025. Their position reflects the need for reliable signal continuity in intensive care, operating rooms, and cardiac monitoring wards. These settings use multi-parameter monitoring systems where interruptions or interference can affect clinical performance. Established suppliers have a strong position because tertiary hospital networks require proven equipment, service support, and compatibility with installed systems. The South America biomedical sensors industry continues to depend on wired configurations for acute and high-acuity care.Wireless sensors are expected to expand at a 12.71% CAGR through 2031. Their use is increasing in step-down units, outpatient pathways, remote monitoring, and home discharge programs. Wired and wireless systems often complement each other rather than replace one another. Philips showcased its PM 6000 patient monitoring platform, featuring the Patient Information Center iX software, in Brazil in May 2026. The platform illustrates how continuous monitoring in critical care can sit alongside wireless data access and early-warning tools for wider hospital use.
Temperature sensors held 31.18% of the South America biomedical sensors market share in 2025. Their broad use covers patient monitoring, pharmaceutical cold-chain management, research laboratories, neonatal care, and critical care. Temperature is a basic clinical measurement that is in high demand across many settings. Pressure, image, inertial, motion, and electrocardiogram sensors serve more specialized needs in diagnostics, cardiovascular care, and imaging-guided procedures. Together, these categories make the South America biomedical sensors industry relevant to both general monitoring and targeted clinical applications.
Biochemical sensors are projected to expand at a 13.89% CAGR through 2031. Demand is linked to diabetes management and wider use of continuous glucose monitoring. Adult diabetes prevalence in the Americas was 13.1% in the 2025 PAHO data. Abbott received FDA authorization for Libre Duo 10 Day in August 2026, a dual glucose-ketone sensor designed to monitor both analytes. FAPESP also supported a 2025 project for a dual-impedimetric platform that monitors glucose and C-peptide using nanocomposite electrodes.
Complete Report Scope:
- By Connectivity Type
- Wired
- Wireless
- By Sensor Type
- Temperature
- Pressure
- Image Sensors
- Biochemical
- Inertial Sensors
- Motion Sensors
- Electrocardiogram (ECG)
- Other Sensor Types
- By End-User Industry
- Pharmaceutical
- Healthcare
- Research Institutions
- Fitness and Wellness
- By Application
- Diagnostics
- Monitoring
- Therapeutics
- Imaging
- Research and Development
- Other Applications
- By Geography
- Brazil
- Argentina
- Colombia
- Rest of South America
List of Companies Covered in this Report:
- Abbott Laboratories
- Analog Devices, Inc.
- Becton, Dickinson and Company
- Biologix
- Boston Scientific Corporation
- Condor Instruments
- Danaher Corporation
- Dexcom, Inc.
- Diasci PD&I
- Edwards Lifesciences Corporation
- GE HealthCare Technologies Inc.
- Honeywell International Inc.
- Koninklijke Philips N.V.
- Masimo Corporation
- Medtronic plc
- NXP Semiconductors N.V.
- Olympus Corporation
- Quoretech
- Sensirion AG
- Siemens Healthineers AG
- ICU Medical, Inc.
- STMicroelectronics N.V.
- Stryker Corporation
- TE Connectivity Ltd.
- Texas Instruments Incorporated
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
1 INTRODUCTION
4 MARKET LANDSCAPE
5 MARKET SIZE AND GROWTH FORECASTS (VALUE)
6 COMPETITIVE LANDSCAPE
7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Analog Devices, Inc.
- Becton, Dickinson and Company
- Biologix
- Boston Scientific Corporation
- Condor Instruments
- Danaher Corporation
- Dexcom, Inc.
- Diasci PD&I
- Edwards Lifesciences Corporation
- GE HealthCare Technologies Inc.
- Honeywell International Inc.
- Koninklijke Philips N.V.
- Masimo Corporation
- Medtronic plc
- NXP Semiconductors N.V.
- Olympus Corporation
- Quoretech
- Sensirion AG
- Siemens Healthineers AG
- ICU Medical, Inc.
- STMicroelectronics N.V.
- Stryker Corporation
- TE Connectivity Ltd.
- Texas Instruments Incorporated
